Loading...
Next-generation sequencing in hematologic malignancies: what will be the dividends?
The application of high-throughput, massively parallel sequencing technologies to hematologic malignancies over the past several years has provided novel insights into disease initiation, progression, and response to therapy. Here, we describe how these new DNA sequencing technologies have been appl...
Saved in:
Main Authors: | , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
SAGE Publications
2012
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3627325/ https://ncbi.nlm.nih.gov/pubmed/23606936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620712458948 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|